Investigation of serum proteome alterations in human glioblastoma multiforme
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigation of serum proteome alterations in human glioblastoma multiforme
Authors
Keywords
-
Journal
PROTEOMICS
Volume 12, Issue 14, Pages 2378-2390
Publisher
Wiley
Online
2012-06-11
DOI
10.1002/pmic.201200002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipid Metabolism Impairment in Human Gliomas: Expression of Peroxisomal Proteins in Human Gliomas at Different Grades of Malignancy
- (2017) E. Benedetti et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- A Novel Molecular Diagnostic of Glioblastomas: Detection of an Extracellular Fragment of Protein Tyrosine Phosphatase μ
- (2015) Susan M. Burden-Gulley et al. NEOPLASIA
- Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
- (2011) Fabio M. Iwamoto et al. JOURNAL OF NEURO-ONCOLOGY
- Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response
- (2011) Sandipan Ray et al. Journal of Proteomics
- Plasma Ceruloplasmin Ferroxidase Activity Correlates with the Nigral Sonographic Area in Parkinson’s Disease Patients: A Pilot Study
- (2011) Rubén Martínez-Hernández et al. NEUROCHEMICAL RESEARCH
- Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach
- (2011) Brigitte Collet et al. Proteome Science
- Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead
- (2011) Sandipan Ray et al. PROTEOMICS
- Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
- (2010) P. Sreekanthreddy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Frequent abnormalities of the immune system in gliomas and correlation with the WHO grading system of malignancy
- (2010) K. Gousias et al. JOURNAL OF NEUROIMMUNOLOGY
- Proteomic Identification of Haptoglobin α2 as a Glioblastoma Serum Biomarker: Implications in Cancer Cell Migration and Tumor Growth
- (2010) Durairaj Mohan Kumar et al. JOURNAL OF PROTEOME RESEARCH
- Glioma proteomics: Status and perspectives
- (2010) Simone P. Niclou et al. Journal of Proteomics
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme
- (2009) M.U. Schuhmann et al. EJSO
- Serum proteomics of glioma: methods and applications
- (2009) Kumaravel Somasundaram et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor
- (2009) Masabumi Shibuya FEBS Journal
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance
- (2009) Niraj Kumar Srivastava et al. NMR IN BIOMEDICINE
- Glycosylation status of vitamin D binding protein in cancer patients
- (2009) Douglas S. Rehder et al. PROTEIN SCIENCE
- The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status
- (2008) S. Abbas et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Serum 2-HS Glycoprotein Predicts Survival in Patients with Glioblastoma
- (2008) V. Petrik et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started